MarketBeat Instant News Alerts 2 hours agoKelt Exploration Ltd. (TSE:KEL) Receives Average Recommendation of "Buy" from AnalystsMarketBeatShares of Kelt Exploration Ltd. (TSE:KEL - Get Free Report) have been given a consensus rating of "Buy" by the five brokerages that are covering the stock, MarketBeat reports. Five analysts have rated the stock with a buy rating. The average 12 month price target among brokers that have issued a rTSE:KELRead Kelt Exploration Ltd. (TSE:KEL) Receives Average Recommendation of "Buy" from Analysts2 hours agoCitigroup Cuts RXO (NYSE:RXO) Price Target to $23.00MarketBeatCitigroup dropped their price objective on shares of RXO from $30.00 to $23.00 and set a "neutral" rating for the company in a report on Friday.NYSE:RXORead Citigroup Cuts RXO (NYSE:RXO) Price Target to $23.002 hours agoRoyal Bank Of Canada Lowers Realty Income (NYSE:O) Price Target to $70.00MarketBeatRoyal Bank Of Canada cut their target price on shares of Realty Income from $71.00 to $70.00 and set an "outperform" rating for the company in a research note on Friday.NYSE:ORead Royal Bank Of Canada Lowers Realty Income (NYSE:O) Price Target to $70.002 hours agoMicrochip Technology (NASDAQ:MCHP) Price Target Lowered to $95.00 at CitigroupMarketBeatCitigroup lowered their target price on shares of Microchip Technology from $113.00 to $95.00 and set a "buy" rating on the stock in a research note on Friday.NASDAQ:MCHPRead Microchip Technology (NASDAQ:MCHP) Price Target Lowered to $95.00 at Citigroup2 hours agoXeris Biopharma Q2 Earnings Call HighlightsMarketBeatXeris Biopharma (NASDAQ:XERS) reported second-quarter total revenue of $92.1 million, up 29% from a year earlier, as net product revenue increased 34% to $91 million. The company raised the low end of its full-year 2026 revenue outlook, now forecasting total revenue of $385 million to $390 million. NASDAQ:XERSRead Xeris Biopharma Q2 Earnings Call Highlights2 hours agoXenon Pharmaceuticals Q2 Earnings Call HighlightsMarketBeat10x Genomics reported second-quarter revenue of $151 million, including $1.6 million in license and royalty revenue tied to its settlement with Takara Bio. Excluding non-recurring settlement revenue in both periods, revenue was $149.4 million, up 3% from the prior-year quarter. Chief Executive OffiNASDAQ:XENERead Xenon Pharmaceuticals Q2 Earnings Call Highlights Trending News1Archer Aviation (ACHR) Projected to Announce Quarterly Earnings on Monday2Celsius Q2 Earnings Call Highlights3Rocket Lab (RKLB) to Post Quarterly Earnings on Monday4Northland Securities Predicts BigBear.ai Q1 Earnings5Plug Power (PLUG) Expected to Release Quarterly Earnings on Monday6Nokia (NYSE:NOK) Shares Up 2.3% - Here's Why7Advanced Micro Devices Q2 Earnings Call Highlights8Ondas (NASDAQ:ONDS) Shares Up 11.7% - Should You Buy? All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoWillScot Q2 Earnings Call HighlightsMarketBeatNASDAQ:WSCRead WillScot Q2 Earnings Call Highlights2 hours agoWilldan Group Q2 Earnings Call HighlightsMarketBeatNASDAQ:WLDNRead Willdan Group Q2 Earnings Call Highlights2 hours agoWhere Food Comes From Q2 Earnings Call HighlightsMarketBeatNASDAQ:WFCFRead Where Food Comes From Q2 Earnings Call Highlights2 hours agoWestrock Coffee Q2 Earnings Call HighlightsMarketBeatNASDAQ:WESTRead Westrock Coffee Q2 Earnings Call Highlights2 hours agoWendy's Q2 Earnings Call HighlightsMarketBeatNASDAQ:WENRead Wendy's Q2 Earnings Call Highlights2 hours agoWarner Bros. Discovery Q2 Earnings Call HighlightsMarketBeatNASDAQ:WBDRead Warner Bros. Discovery Q2 Earnings Call Highlights2 hours agoVerastem Q2 Earnings Call HighlightsMarketBeatNASDAQ:VSTMRead Verastem Q2 Earnings Call Highlights2 hours agoIamgold (NYSE:IAG) Trading 13.7% Higher - What's Next?MarketBeatNYSE:IAGRead Iamgold (NYSE:IAG) Trading 13.7% Higher - What's Next?2 hours agoTMC the metals (NASDAQ:TMC) Stock Price Up 14.2% - Time to Buy?MarketBeatNASDAQ:TMCRead TMC the metals (NASDAQ:TMC) Stock Price Up 14.2% - Time to Buy?2 hours agoCitigroup Lowers Micron Technology (NASDAQ:MU) Price Target to $1,150.00MarketBeatNASDAQ:MURead Citigroup Lowers Micron Technology (NASDAQ:MU) Price Target to $1,150.002 hours agoLoar (NYSE:LOAR) Stock Price Expected to Rise, Royal Bank Of Canada Analyst SaysMarketBeatNYSE:LOARRead Loar (NYSE:LOAR) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says2 hours agoLyft (NASDAQ:LYFT) Stock Price Expected to Rise, Royal Bank Of Canada Analyst SaysMarketBeatNASDAQ:LYFTRead Lyft (NASDAQ:LYFT) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says2 hours agoLigand Pharmaceuticals (NASDAQ:LGND) Stock Price Expected to Rise, Royal Bank Of Canada Analyst SaysMarketBeatNASDAQ:LGNDRead Ligand Pharmaceuticals (NASDAQ:LGND) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says2 hours agoDatadog (NASDAQ:DDOG) Price Target Raised to $305.00 at CitigroupMarketBeatNASDAQ:DDOGRead Datadog (NASDAQ:DDOG) Price Target Raised to $305.00 at Citigroup2 hours agoAdtalem Global Education (NYSE:CVSA) Shares Up 13.6% Following Earnings BeatMarketBeatNYSE:CVSARead Adtalem Global Education (NYSE:CVSA) Shares Up 13.6% Following Earnings Beat2 hours agoRoyal Bank Of Canada Increases EPR Properties (NYSE:EPR) Price Target to $64.00MarketBeatNYSE:EPRRead Royal Bank Of Canada Increases EPR Properties (NYSE:EPR) Price Target to $64.002 hours agoEvommune (NYSE:EVMN) Price Target Cut to $29.00 by Analysts at Royal Bank Of CanadaMarketBeatNYSE:EVMNRead Evommune (NYSE:EVMN) Price Target Cut to $29.00 by Analysts at Royal Bank Of Canada2 hours agoCalumet (NASDAQ:CLMT) Trading Down 6.7% on Disappointing EarningsMarketBeatNASDAQ:CLMTRead Calumet (NASDAQ:CLMT) Trading Down 6.7% on Disappointing Earnings3 hours agoRepublic Services (NYSE:RSG) Given New $240.00 Price Target at BarclaysMarketBeatNYSE:RSGRead Republic Services (NYSE:RSG) Given New $240.00 Price Target at Barclays3 hours agoParker-Hannifin's (PH) "Outperform" Rating Reiterated at BNP Paribas ExaneMarketBeatNYSE:PHRead Parker-Hannifin's (PH) "Outperform" Rating Reiterated at BNP Paribas Exane3 hours agoBarclays Has Lowered Expectations for NiSource (NYSE:NI) Stock PriceMarketBeatNYSE:NIRead Barclays Has Lowered Expectations for NiSource (NYSE:NI) Stock Price3 hours agoRoyal Bank Of Canada Increases Cloudflare (NYSE:NET) Price Target to $346.00MarketBeatNYSE:NETRead Royal Bank Of Canada Increases Cloudflare (NYSE:NET) Price Target to $346.003 hours agoRoyal Bank Of Canada Issues Pessimistic Forecast for DuPont de Nemours (NYSE:DD) Stock PriceMarketBeatNYSE:DDRead Royal Bank Of Canada Issues Pessimistic Forecast for DuPont de Nemours (NYSE:DD) Stock Price3 hours agoRoyal Bank Of Canada Issues Positive Forecast for Ducommun (NYSE:DCO) Stock PriceMarketBeatNYSE:DCORead Royal Bank Of Canada Issues Positive Forecast for Ducommun (NYSE:DCO) Stock Price Featured Articles and OffersSpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have ControlBy Jeffrey Neal Johnson | August 3, 2026Your $29.97 book is free todayFrom Profits Run (Ad)3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income StoryBy Nathan Reiff | August 2, 2026System Upgrade: First Internet Bancorp Options SurgeBy Jeffrey Neal Johnson | August 4, 2026Tilray Brands (NASDAQ:TLRY) Rating Increased to Strong-Buy at TD SecuritiesBy MarketBeat | August 1, 2026Three companies about to leapfrog Nvidia [And transform the entire industry]From Eagle Publishing (Ad)AMD’s Post-Earnings Drop May Be the Opportunity Investors WantedBy Thomas Hughes | August 5, 2026AbbVie Quietly Solved Its Biggest Problem—Now What?By Thomas Hughes | August 2, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 570 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
